Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium usnate is a water-soluble potassium salt of usnic acid, a naturally occurring dibenzofuran derivative found in various lichen species. Developed by researchers at Sunchon National University and Chonnam National University, this formulation aims to improve the poor aqueous solubility and low bioavailability of the parent compound, usnic acid. In preclinical studies, potassium usnate has demonstrated significant antineoplastic activity, particularly in colorectal cancer models, where it inhibits tumor cell invasion and liver metastasis. Its mechanism of action involves the downregulation of key epithelial-mesenchymal transition (EMT) transcription factors, including Twist, Snail, and Slug, as well as several metastasis-associated genes such as CDC42, WASL, and CAPN1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium usnate.